TrialInternational journal of radiation oncology, biology, physics2019

Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.

Frank S Lieberman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.